Examples of using Transdermal patch in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Use only one transdermal patch at a time.
It is a new method of fighting excess pounds,based on a transdermal patch.
Only one transdermal patch should be worn at a time.
Istodobno se smije koristiti samo jednim transdermalnim flasterom.Mibiomi Patches- high efficiency of use thanks to the transdermal patch.
Mibiomi zakrpe- visoka učinkovitost primjene zahvaljujući transdermalnom flasteru.The transdermal patch may be affected by direct sunlight or exposure to sunlamps.
Na transdermalni flaster može utjecati izravna sunčeva svjetlost ili izlaganje UV-lampama.Steady-state conditions are reached during the second application of the transdermal patch.
Stanje dinamičke ravnoteže doseže se pri drugoj primjeni transdermalnog flastera.Consider using the 4.6 mg/24 h transdermal patch both as initial and maximum dose in these patients.
Potrebno je razmotriti korištenje transdermalnog flastera od 4, 6 mg/24 h kao početne i kao maksimalne doze u tih bolesnika.Transdermal patch treatment can be resumed at the same dose if treatment is not interrupted for more than three days.
Liječenje transdermalnim flasterom može se nastaviti u istoj dozi, ako liječenje nije prekinuto na duže od tri dana.Following application, rotigotine is continuously released from the transdermal patch and absorbed through the skin.
Nakon primjene rotigotin se kontinuirano otpušta iz transdermalnog flastera i apsorbira kroz kožu.Transdermal patch treatment can be resumed at the same dose if treatment is not interrupted for more than three days.
Liječenje transdermalnim flasterom može se nastaviti s istom dozom ako liječenje nije bilo prekinuto dulje od tri dana.If your arms are not suitable areas to apply the transdermal patch your doctor may ask you to put it on your abdomen.
Ako nadlaktice nisu prikladne za primjenu transdermalnog flastera, liječnik Vam može predložiti da ga stavite na kožu trbuha.The transdermal patch Change Day will be on this day every week cycle Days 8, 15, 22 and Day 1 of the next cycle.
Dan izmjene transdermalnog flastera isti je dan u svakom sljedećem tjednu 8., 15., 22. dan ciklusa te 1. dan sljedećeg ciklusa.Patients and their caregivers must be instructed on important administration instructions for Rivastigmine 3M Health Care Ltd. transdermal patch see section 4.2.
Bolesnici i njihovi njegovatelji moraju dobiti važne upute o primjeni Rivastigmin 3M Health Care Ltd. transdermalnog flastera vidjeti dio 4.2.It has not been shown that a transdermal patch like EVRA is safer than a combined birth control pill taken by mouth.
Nije dokazano da je transdermalni flaster poput EVRE sigurniji od kombinirane kontracepcijske tablete koja se uzima kroz usta.Unchanged rivastigmine is found in traceamounts in the urine; renal excretion of the metabolites is the major route of elimination after transdermal patch administration.
Nepromijenjeni rivastigmin nalazi se u tragovima u mokraći;glavni put eliminacije je izlučivanje metabolita putem bubrega nakon primjene transdermalnog flastera.Consider using the 4.6 mg/24 h transdermal patch both as initial and maximum dose in these patients.
Potrebno je razmisliti o korištenju transdermalnog flastera u dozi od 4, 6 mg/24 h kao početne i kao maksimalne doze u tih bolesnika.Application site skin reactions(usually mild to moderate application site erythema),are the most frequent adverse reactions observed with the use of Exelon transdermal patch.
Kožne reakcije na mjestu primjene(obično blagi do umjerenieritem na mjestu primjene), najučestalije su nuspojave uočene s primjenom Exelon transdermalnih flastera.The granisetron transdermal patch was applied 24 to 48 hours prior to the first dose of chemotherapy, and kept in place for 7 days.
Transdermalni flaster s granizetronom primijenjen je 24 do 48 sati prije prve doze kemoterapije i ostavljen je na mjestu 7 dana.Keep the skin where this medicine was applied covered for another 10 days after the transdermal patch is taken off to protect from exposure to direct sunlight.
Kožu na kojoj je bio zalijepljen ovaj lijek držite pokrivenu još 10 dana nakon uklanjanja transdermalnog flastera kako biste je zaštitili od izravne sunčeve svjetlosti.While you wear the transdermal patch, keep it covered with clothing if you will be in sunlight or near a sunlamp, including tanning beds.
Dok nosite transdermalni flaster, držite ga pokrivenim odjećom ako ćete se izlagati sunčevoj svjetlosti ili svjetlu UV-lampi, uključujući solarij.Do not put SANCUSO on areas that have been treated with creams, oils, lotions, powders orother skin products that could keep the transdermal patch from sticking well to your skin.
Nemojte stavljati SANCUSO na područja na koja ste nanijeli kreme, ulja, losione,pudere ili druge proizvode za kožu zbog kojih se transdermalni flaster ne bi dobro prilijepio za kožu.While you are wearing the transdermal patch you must keep it covered, e.g. under clothing, if there is a risk of exposure to sunlight or sunlamps.
Dok nosite transdermalni flaster pazite da bude pokriven, na primjer ispod odjeće, ako postoji opasnost od izlaganja sunčevoj svjetlosti ili UV-lampama.If severe reactions, or a generalised skin reaction occur(e.g. allergic rash, including erythematous, macular,papular rash or pruritus), the transdermal patch must be removed.
U slučaju teških reakcija ili generalizirane kožne reakcije(npr. alergijskog osipa, uključujući eritematozni, makularni,papulozni osip ili svrbež), potrebno je ukloniti transdermalni flaster.Each used transdermal patch is removed and immediately replaced with a new one on the same day of the week(Change Day) on Day 8 and Day 15 of the cycle.
Svaki upotrijebljeni transdermalni flaster treba skinuti te odmah zamjeniti novim, uvijek istog dana u tjednu(tzv. dan izmjene) na 8. i 15. dan ciklusa.Although, the clinical relevance of this finding is not completely clear,patients should be advised to cover the transdermal patch application site if there is a risk of exposure to sunlight throughout the period of wear and for 10 days following its removal see section 4.4.
Iako klinički značaj tog otkrića nije potpuno jasan,bolesnike je potrebno savjetovati da pokriju mjesto primjene transdermalnog flastera ako postoji opasnost od izlaganja sunčevoj svjetlosti tijekom razdoblja nošenja i 10 dana nakon uklanjanja vidjeti dio 4.4.If transdermal patch use results in uncomfortable irritation, a new transdermal patch may be applied to a new location until the next Change Day.
Ako primjena A new contraceptive cycle begins on the next day following transdermal patch-free week;the next EVRA transdermal patch should be applied even if there has been no withdrawal bleeding or if withdrawal bleeding has not yet stopped.
Novi kontracepcijski ciklus započinje prvog dana nakon isteka tjedna u kojem se Capsaicin transdermal patch(Qutenza) for the management of this particular therapeutic indication(pain due to post-herpetic neuralgia) was approved as a therapeutic by the U.S. FDA.
Transdermalni flaster kapsaicina(Qutenza) za upravljanje ovom posebnom terapijskom indikacijom(bol zbog postherpetičke neuralgije) odobren je kao terapeutski od strane US FDA.After removal, the used transdermal patch should be folded firmly in half, adhesive side inwards and then discarded out of the reach of children.
Nakon uklanjanja, iskorišteni transdermalni flaster je potrebno čvrsto presaviti na pola, s ljepljivom stranom prema unutra, i zatim baciti izvan dohvata djece.After transdermal patch application, the apparent granisetron plasma half-life in healthy subjects was prolonged to approximately 36 hours due to the slow absorption rate of granisetron through the skin.
Nakon primjene transdermalnog flastera, prividni poluvijek granizetrona u plazmi u zdravih ispitanika produžen je na približno 36 sati zbog spore apsorpcije granizetrona kroz kožu.
